BSE filing, NSE: TMPV. Summary written from the filing by ALFA Finder's alert engine.
Tata Motors Passenger Vehicles Ltd: key numbers
- Share price
- ₹266.00
- Market cap
- ₹97,968 Cr
- Revenue (annual)
- ₹3,35,582 Cr
- Net profit (annual)
- ₹82,390 Cr
- P/E (TTM)
- 1.2×Sector 30.9×
- Promoter holding
- 42.50%-0.01% QoQ
- FII holding
- 15.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Motors Passenger Vehicles Ltd
All →Tata Motors Passenger Vehicles Board Meeting Date
Tata Motors Passenger Vehicles will hold a board meeting on 13 November 2026 to approve Q2 and half-year results. An analyst call follows the results announcement.
Tata Motors Passenger Vehicles Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine periodic disclosure mandated by SEBI regulations.
Tata Motors Passenger Vehicles Partnership
TMPV and Stellantis sign a Definitive Agreement expanding their partnership into advanced vehicle technology collaboration. Vehicles will be built at their 50:50 JV, FIAPL, for global markets.
Tata Motors Passenger Vehicles Debt & Borrowing
Tata Motors Passenger Vehicles filed its half-yearly debt securities compliance report as of September 30, 2026. The filing details three outstanding NCD tranches maturing in 2028.
Tata Motors Passenger Vehicles Business Update
Tata Motors Passenger Vehicles recorded sales of 201,723 units in Q2 FY27, marking 40% year-on-year growth. EV sales grew 90% to over 47,000 units during the quarter.
- quarterly sales volume
- 201723.0 units
Tata Motors Passenger Vehicles Price Movement Clarification
Tata Motors Passenger Vehicles clarified that it has no knowledge of any negotiations mentioned in the news report regarding the company.
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.